health pharma news today obesity drugs glp-1 World Organization recommends for GLP-1 drugs, which have grown

Footnotes Authors Vidal and Akiska Co-first authors with equal contributions

Metformin, on the other hand, usually causes mild digestive issues that tend to improve over time

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, more recently, chronic weight management

The medication also has mild antidepressant effects, which can benefit people dealing with both mood issues and weight management simultaneously

Bringing addiction treatment 'inside the house of medicine' In addition to food addiction, GLP-1s show promise for opioid, alcohol and nicotine addiction Early studies suggest that GLP-1s may be effective in treating opioid, alcohol and nicotine addiction

Exclusion criteria observed in Phase 2 trials included individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, given the class-level concern with GLP-1 receptor agonists and C-cell tumours in rodent models [8]